Skip to main content
Clinical Trials/NCT02235571
NCT02235571
Completed
Not Applicable

iChoose Kidney Decision Aid for Treatment Options Among End-Stage Renal Disease (ESRD) Patients

Emory University3 sites in 1 country470 target enrollmentSeptember 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
End-Stage Kidney Disease
Sponsor
Emory University
Enrollment
470
Locations
3
Primary Endpoint
Effectiveness of the iChoose Kidney intervention to improve knowledge and shared decision-making between patients and physicians regarding ESRD treatment options.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The investigators developed iChoose Kidney -- a shared decision-making support tool accessible through iPad, iPhone, or the web -- to provide ESRD patients and their providers with a simple, standardized, easily accessible, statistically robust tool for use in the clinic to guide patient education and healthcare decision-making about treatment options of dialysis or kidney transplantation. The iChoose Kidney decision aid provides patients with estimates of their individualized 1 and 3-year risks of mortality on dialysis vs. transplantation, based on previous national data. The tool has the potential to improve communication and decision-making between patients and their healthcare providers and improve access to kidney transplantation among patients with ESRD.

This will be a two-arm, randomized study, and will be conducted at 3 large transplant centers with diverse patient populations. One group of patients will receive standard education alone during their scheduled transplant evaluation. The second group will receive the standard education as well have the provider use the iChoose Kidney aid with them. The project timeline will be a total of 24 months inclusive of enrollment, follow-up, data analysis, and outcome evaluation.

This study will assess how well the iChoose decision aid works in improving patient knowledge, preferences for treatment, and patient access to transplant. The study will also assess whether providers find the tool useful for providing ways to share information with patients about ways to treat their kidney disease.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
September 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rachel Patzer, PhD

Assistant Professor

Emory University

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of end-stage renal disease (ESRD) and on dialysis for \< 1 year
  • English-speaking
  • Subjects coming in for transplant medical evaluation
  • Age \> 18 years

Exclusion Criteria

  • Severe cognitive or visual impairment

Outcomes

Primary Outcomes

Effectiveness of the iChoose Kidney intervention to improve knowledge and shared decision-making between patients and physicians regarding ESRD treatment options.

Time Frame: Up to 19 months

Patient knowledge of the survival benefit of transplant and the patient's individualized mortality risk

Secondary Outcomes

  • Patient access to transplant(Up to 19 months)

Study Sites (3)

Loading locations...

Similar Trials